Related Experiment Videos
Thymidine kinase: diagnostic and prognostic potential.
K L O'Neill1, M R Buckwalter, B K Murray
1Department of Microbiology, Brigham Young University, Provo, UT, USA. kim_oneil@byu.edu
Expert Review of Molecular Diagnostics
|March 21, 2002
Summary
Thymidine kinase, a cancer marker, can be detected in serum and tumor tissue. A new, low-cost assay shows promise for cancer detection and monitoring treatment effectiveness.
Area of Science:
- Biochemistry
- Oncology
- Immunology
Background:
- Thymidine kinase (TK) is a cell cycle-dependent enzyme.
- Elevated serum TK levels are observed in various cancers and correlate with disease progression and treatment response.
- Current detection methods may be limited in scope or cost-effectiveness.
Purpose of the Study:
- To introduce a novel monoclonal antibody-based assay for thymidine kinase detection.
- To evaluate the utility of this assay in both serum and tumor tissue samples.
- To assess the potential of a low-cost thymidine kinase assay for cancer diagnostics.
Main Methods:
- Development of a new monoclonal antibody assay targeting thymidine kinase.
- Application of the assay to detect thymidine kinase in patient serum.
- Application of the assay to detect thymidine kinase in tumor tissue specimens.
Main Results:
- The developed assay successfully detects thymidine kinase in both serum and tumor tissue.
- Serum thymidine kinase levels reflect cancer progression and therapeutic efficacy.
- The assay demonstrates potential for broad application across various cancer types.
Conclusions:
- A new, cost-effective monoclonal antibody assay for thymidine kinase has been developed.
- This assay can detect thymidine kinase in serum and tumor tissue, aiding cancer detection and monitoring.
- Low-cost thymidine kinase assays hold significant potential for improving cancer management strategies.